Medicine
Glipizide 5 mg extended-release tablet
Glipizide 5 mg extended-release tablet is a generic prescription medicine for oral use, made by 9 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F). The tablets should be protected from…
Key facts
- Active ingredient (INN)
- Glipizide
- Brand
- Sold under the generic name
- Strength
- 5 mg
- Dosage form
- Extended-release tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets, 30 tablets and 26 more
- Manufacturers
- Aurobindo PharmaIndiaBryant Ranch PrepackA-S Medication SolutionsNorthwind HealthRemedyrepackRising Pharma HoldingsNorthStar RxAmerican Health PackagingSt. Mary's Medical Park Pharmacy
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F). The tablets should be protected from moisture and humidity.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A10BB07 Glipizide
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 24 April 2017
- Identifiers
- RxCUI 314006, 310489, 315107DailyMed set ID 0a1e1152-ade7-2092-e063-6394a90a99e7, ab2f4ea6-46e8-268a-e053-2995a90a3977, 0338aff9-29f9-405e-b516-06ef4b863863 +10NDC 82868-025, 51655-337, 71335-1031 +10Application ANDA206928, ANDA204720, ANDA203499
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, extended release in 1 bottle | 59651-781-01 | Aurobindo PharmaIndia | 3 March 2023 |
| 500 tablet, extended release in 1 bottle | 59651-781-05 | Aurobindo PharmaIndia | 3 March 2023 |
| 30 tablet, extended release in 1 bottle | 59651-781-30 | Aurobindo PharmaIndia | 3 March 2023 |
| 100 tablet, film coated, extended release in 1 bottle, plastic | 64980-280-01 | Rising Pharma Holdings | 24 April 2017 |
| 500 tablet, film coated, extended release in 1 bottle, plastic | 64980-280-05 | Rising Pharma Holdings | 24 April 2017 |
| 1000 tablet, film coated, extended release in 1 bottle, plastic | 64980-280-10 | Rising Pharma Holdings | 24 April 2017 |
| 30 tablet, film coated, extended release in 1 bottle | 50090-5040-0 | A-S Medication Solutions | 12 May 2020 |
| 90 tablet, film coated, extended release in 1 bottle | 50090-5040-2 | A-S Medication Solutions | 12 May 2020 |
| 30 tablet, extended release in 1 bottle | 50090-6746-0 | A-S Medication Solutions | 18 October 2023 |
| 60 tablet, extended release in 1 bottle | 50090-6746-1 | A-S Medication Solutions | 16 October 2023 |
| 90 tablet, extended release in 1 bottle | 50090-6746-2 | A-S Medication Solutions | 16 October 2023 |
| 90 tablet, film coated, extended release in 1 bottle | 71335-1031-1 | Bryant Ranch Prepack | 7 January 2019 |
| 30 tablet, film coated, extended release in 1 bottle | 71335-1031-2 | Bryant Ranch Prepack | 7 January 2019 |
| 60 tablet, film coated, extended release in 1 bottle | 71335-1031-3 | Bryant Ranch Prepack | 7 January 2019 |
| 100 tablet, film coated, extended release in 1 bottle | 71335-1031-4 | Bryant Ranch Prepack | 7 January 2019 |
| 90 tablet, extended release in 1 bottle | 71335-9742-1 | Bryant Ranch Prepack | 9 April 2026 |
| 30 tablet, extended release in 1 bottle | 71335-9742-2 | Bryant Ranch Prepack | 26 June 2023 |
| 60 tablet, extended release in 1 bottle | 71335-9742-3 | Bryant Ranch Prepack | 9 April 2026 |
| 100 tablet, extended release in 1 bottle | 71335-9742-4 | Bryant Ranch Prepack | 14 July 2023 |
| 90 tablet, film coated, extended release in 1 bottle, plastic | 51655-337-26 | Northwind Health | 26 May 2020 |
| 30 tablet, extended release in 1 bottle, plastic | 82868-025-30 | Northwind Health | 3 January 2024 |
| 90 tablet, extended release in 1 bottle, plastic | 82868-025-90 | Northwind Health | 8 November 2023 |
| 30 tablet, film coated, extended release in 1 blister pack | 70518-1063-0 | Remedyrepack | 13 March 2018 |
| 90 tablet, film coated, extended release in 1 bottle, plastic | 70518-1063-1 | Remedyrepack | 21 March 2018 |
| 90 tablet, extended release in 1 bottle, plastic | 70518-3898-0 | Remedyrepack | 17 October 2023 |
| 100 blister pack in 1 carton / 1 tablet, extended release in 1 blister pack | 60687-881-01 | American Health Packaging | 4 April 2025 |
| 100 tablet, extended release in 1 bottle | 16714-895-01 | Northstar Rx | 1 December 2018 |
| 500 tablet, extended release in 1 bottle | 16714-895-02 | Northstar Rx | 1 December 2018 |
| 30 tablet, extended release in 1 bottle, plastic | 60760-794-30 | St. Mary's Medical Park Pharmacy | 12 June 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 8 May 1984 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Glipizide 5 mg extended-release tablet.
Other strengths and forms of Glipizide
Clinical summary
Glipizide is a sulfonylurea indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is available as tablets and extended-release tablets for oral use. MedsAcross supplies Glipizide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about GlipizideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Glucotrol XL prescribing information (Roerig) · U.S. National Library of Medicine, DailyMed
Need Glipizide 5 mg extended-release tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.